Cargando…

Oral contraceptives combined with interferon β in multiple sclerosis

OBJECTIVE: To test the effect of oral contraceptives (OCs) in combination with interferon β (IFN-β) on disease activity in patients with relapsing-remitting multiple sclerosis (RRMS). METHODS: One hundred fifty women with RRMS were randomized in a 1:1:1 ratio to receive IFN-β-1a subcutaneously (SC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pozzilli, Carlo, De Giglio, Laura, Barletta, Valeria T., Marinelli, Fabiana, Angelis, Floriana De, Gallo, Valentina, Pagano, Veronica A., Marini, Stefano, Piattella, Maria C., Tomassini, Valentina, Pantano, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476053/ https://www.ncbi.nlm.nih.gov/pubmed/26140279 http://dx.doi.org/10.1212/NXI.0000000000000120

Ejemplares similares

Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis
por: De Giglio, L., et al.
Publicado: (2015)

Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?
por: Prosperini, Luca, et al.
Publicado: (2011)

Functional Connectivity Changes After Initial Treatment With Fingolimod in Multiple Sclerosis
por: Petsas, Nikolaos, et al.
Publicado: (2019)

Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases
por: Nistri, Riccardo, et al.
Publicado: (2021)

Similarities and differences between multiple sclerosis and type 1 diabetes
por: Pozzilli, Valeria, et al.
Publicado: (2021)

Evidence of Impaired Brain Activity Balance after Passive Sensorimotor Stimulation in Multiple Sclerosis
por: Petsas, Nikolaos, et al.
Publicado: (2013)

The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence
por: Tomassini, Valentina, et al.
Publicado: (2016)

Functional and Structural Brain Plasticity Enhanced by Motor and Cognitive Rehabilitation in Multiple Sclerosis
por: Prosperini, Luca, et al.
Publicado: (2015)

Neutralizing antibodies explain the poor clinical response to Interferon beta in a small proportion of patients with Multiple Sclerosis: a retrospective study
por: Sbardella, Emilia, et al.
Publicado: (2009)

Predicting the profile of increasing disability in multiple sclerosis
por: Tomassini, Valentina, et al.
Publicado: (2018)

A Comprehensive Approach to Disentangle the Effect of Cerebellar Damage on Physical Disability in Multiple Sclerosis
por: Ruggieri, Serena, et al.
Publicado: (2020)

A matter of atrophy: differential impact of brain and spine damage on disability worsening in multiple sclerosis
por: Ruggieri, Serena, et al.
Publicado: (2021)

Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosis
por: Tommasin, Silvia, et al.
Publicado: (2021)

No Changes in Functional Connectivity After Dimethyl Fumarate Treatment in Multiple Sclerosis
por: Piervincenzi, Claudia, et al.
Publicado: (2022)

Increased Within-Network Functional Connectivity May Predict NEDA Status in Fingolimod-Treated MS Patients
por: Piervincenzi, Claudia, et al.
Publicado: (2021)

Assessing the Correlation between Grey and White Matter Damage with Motor and Cognitive Impairment in Multiple Sclerosis Patients
por: Sbardella, Emilia, et al.
Publicado: (2013)

Relation of sensorimotor and cognitive cerebellum functional connectivity with brain structural damage in patients with multiple sclerosis and no disability
por: Tommasin, Silvia, et al.
Publicado: (2022)

Are Neurophysiological Biomarkers Able to Discriminate Multiple Sclerosis Clinical Subtypes?
por: Belvisi, Daniele, et al.
Publicado: (2022)

Neuroplasticity and Motor Rehabilitation in Multiple Sclerosis
por: Lipp, Ilona, et al.
Publicado: (2015)

Potential Protective Role of Pregnancy and Breastfeeding in Delaying Onset Symptoms Related to Multiple Sclerosis
por: Logoteta, Alessandra, et al.
Publicado: (2023)

Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trial
por: Pozzilli, Carlo, et al.
Publicado: (2021)

Evaluation of Disability Progression in Multiple Sclerosis via Magnetic-Resonance-Based Deep Learning Techniques
por: Taloni, Alessandro, et al.
Publicado: (2022)

Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment
por: Rispoli, Marianna Gabriella, et al.
Publicado: (2021)

Multiple Sclerosis Treatment and Melanoma Development
por: Carbone, Maria Luigia, et al.
Publicado: (2020)

The added value of spinal cord lesions to disability accrual in multiple sclerosis
por: Ruggieri, Serena, et al.
Publicado: (2023)

Eating Hubs in Multiple Sclerosis: Exploring the Relationship Between Mediterranean Diet and Disability Status in Italy
por: Felicetti, Federica, et al.
Publicado: (2022)

Pathophysiology of multiple sclerosis damage and repair: Linking cerebral hypoperfusion to the development of irreversible tissue loss in multiple sclerosis using magnetic resonance imaging
por: Mascali, Daniele, et al.
Publicado: (2023)

Cerebrovascular reactivity in multiple sclerosis is restored with reduced inflammation during immunomodulation
por: Chiarelli, Antonio Maria, et al.
Publicado: (2022)

The Clinical Relevance of Force Platform Measures in Multiple Sclerosis: A Review
por: Prosperini, Luca, et al.
Publicado: (2013)

The Role of fMRI in the Assessment of Neuroplasticity in MS: A Systematic Review
por: Laura, De Giglio, et al.
Publicado: (2018)

Erratum to “The Role of fMRI in the Assessment of Neuroplasticity in MS: A Systematic Review”
por: De Giglio, Laura, et al.
Publicado: (2019)

Paediatric transverse myelitis during COVID-19 asymptomatic infection: A case report
por: Grasso, Eleonora, et al.
Publicado: (2021)

Abnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Bharti, Komal, et al.
Publicado: (2017)

Emerging oral treatments in multiple sclerosis – clinical utility of cladribine tablets
por: Gasperini, Claudio, et al.
Publicado: (2010)

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)
por: Comi, Giancarlo, et al.
Publicado: (2017)

Diagnosis and management of multiple sclerosis: MRI in clinical practice
por: Tomassini, Valentina, et al.
Publicado: (2020)

DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications
por: Sbardella, Emilia, et al.
Publicado: (2013)

Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4
por: Centonze, Diego, et al.
Publicado: (2023)

Lecture notes in cosmology
por: Piattella, Oliver
Publicado: (2018)

Advances in the treatment of relapsing—remitting multiple sclerosis — critical appraisal of fingolimod
por: Gasperini, Claudio, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ph5urhoss7338ombpa01b0omg6